
White House races to restore biosecurity guardrails as AI-biology fears mount
The White House is rushing to rebuild a depleted biosecurity apparatus after staffing cuts under the Trump administration, with Biden-era directives delayed and AI-biotech safeguards still unsettled even as tech firms warn of increasing bio capabilities; experts say reduced funding and reorganizations have weakened coordination across agencies, though officials and industry players are pursuing new safeguards and collaborations to strengthen deterrence and defense against biothreats.













